| Literature DB >> 28428901 |
Lauren Pearson1, Erinc Akture2, Julien Wonderlick3, Gregory Fuller4, Maryam Zenali1.
Abstract
Schwannoma is a benign peripheral nerve sheath tumor that typically involves cranial nerves of the head and neck region. Intraparenchymal occurrence of this tumor is uncommon. Even rarer in this site is the microcystic/reticular pattern of schwannoma. This histologic variant, first described in 2008, has a predilection for visceral organs. Herein, we report the first case of microcystic/reticular schwannoma of the frontal lobe.Entities:
Year: 2017 PMID: 28428901 PMCID: PMC5385903 DOI: 10.1155/2017/4728585
Source DB: PubMed Journal: Case Rep Pathol ISSN: 2090-679X
Figure 1Precontrast axial (a), postcontrast axial (b), and postcontrast left parasagittal (c) T1-weighted MR images of the brain demonstrate an intra-axial left frontal mass with heterogeneous internal nodular and septal enhancement. The largest enhancing component is subjacent to markedly thinned medial left frontal cortex. T2-weighted axial images (d) demonstrate hyperintense cystic formation with near complete suppression on FLAIR sequences (e). No peritumoral T2 hyperintensity is present to suggest vasogenic edema or gliosis. Details from high-resolution, heavily T2-weighted images (f) redemonstrate mixed solid and cystic components and thin internal septation. No elevated perfusion or abnormally restricted diffusion was identified on MR perfusion or diffusion-weighted imaging, respectively (not shown).
Figure 2Photomicrographs of hematoxylin and eosin sections: (A) microcystic/reticular foci with a myxoid appearance adjacent to denser spindle cell areas (100x magnification); (B) microcystic areas with vacuolated cells; and (C) bland spindle cells with palisading configurations (B&C: 400x magnification).
Figure 3Photomicrographs of immunohistochemical stains: (A) S-100 (400x): nuclear and cytoplasmic staining in tumor cells, (B) progesterone receptor (400x): focal staining and (B inset) estrogen receptor (100x): no staining in tumor, and (C) GFAP (400x) and (D) EMA (100x): negative staining in tumor.